Renal Hemodynamic Effects of RLX030A in Subjects With Chronic Heart Failure (CHF)

NCT01546532 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

118

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Heart Failure (CHF)

Interventions

DRUG: RLX030
DRUG: Placebo

Sponsor

Novartis Pharmaceuticals